Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Healthtrust
Johnson and Johnson
Argus Health
Chubb
Colorcon
Dow
Cipla
Fish and Richardson
AstraZeneca

Generated: October 21, 2017

DrugPatentWatch Database Preview

TERRAMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Terramycin, and when can generic versions of Terramycin launch?

Terramycin is a drug marketed by Pfizer and Casper Pharma Llc and is included in eight NDAs.

The generic ingredient in TERRAMYCIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.

Summary for Tradename: TERRAMYCIN

US Patents:0
Applicants:2
NDAs:8
Bulk Api Vendors: see list51
Patent Applications: see list5,317
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERRAMYCIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TERRAMYCIN
lidocaine hydrochloride; oxytetracycline
INJECTABLE;INJECTION060567-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline
TABLET;ORAL050287-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
CAPSULE;ORAL050286-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline calcium
SYRUP;ORAL060595-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
lidocaine hydrochloride; oxytetracycline
INJECTABLE;INJECTION060567-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
CAPSULE;ORAL050286-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
INJECTABLE;INJECTION060586-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
INJECTABLE;INJECTION060586-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Casper Pharma Llc
TERRAMYCIN W/ POLYMYXIN B SULFATE
oxytetracycline hydrochloride; polymyxin b sulfate
OINTMENT;OPHTHALMIC061015-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN-POLYMYXIN
oxytetracycline hydrochloride; polymyxin b sulfate
TABLET;VAGINAL061009-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Accenture
Mallinckrodt
Covington
UBS
AstraZeneca
QuintilesIMS
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot